» Articles » PMID: 20082560

A Systematic Review of Directly Applied Biologic Therapies for Acute Spinal Cord Injury

Overview
Journal J Neurotrauma
Publisher Mary Ann Liebert
Date 2010 Jan 20
PMID 20082560
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

An increasing number of therapies for spinal cord injury (SCI) are emerging from the laboratory and seeking translation into human clinical trials. Many of these are administered as soon as possible after injury with the hope of attenuating secondary damage and maximizing the extent of spared neurologic tissue. In this article, we systematically reviewed the available preclinical research on such neuroprotective therapies that are administered in a non-invasive manner for acute SCI. Specifically, we reviewed treatments that have a relatively high potential for translation due to the fact that they are already used in human clinical applications or are available in a form that could be administered to humans. These included: erythropoietin, NSAIDs, anti-CD11d antibodies, minocycline, progesterone, estrogen, magnesium, riluzole, polyethylene glycol, atorvastatin, inosine, and pioglitazone. The literature was systematically reviewed to examine studies in which an in vivo animal model was utilized to assess the efficacy of the therapy in a traumatic spinal cord injury paradigm. Using these criteria, 122 studies were identified and reviewed in detail. Wide variations exist in the animal species, injury models, and experimental designs reported in the preclinical literature on the therapies reviewed. The review highlights the extent of investigation that has occurred in these specific therapies, and points out gaps in our knowledge that would be potentially valuable prior to human translation.

Citing Articles

Chondroitinase ABC Administration in Locomotion Recovery After Spinal Cord Injury: A Systematic Review and Meta-analysis.

Yousefifard M, Janzadeh A, Ali K, Vazirizadeh-Mahabadi M, Sarveazad A, Madani Neishaboori A Basic Clin Neurosci. 2023; 13(5):609-624.

PMID: 37313020 PMC: 10258590. DOI: 10.32598/bcn.2021.1422.1.


Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-Analysis.

Panizzutti B, Skvarc D, Lin S, Croce S, Meehan A, Bortolasci C Int J Mol Sci. 2023; 24(6).

PMID: 36982324 PMC: 10049047. DOI: 10.3390/ijms24065250.


Passive Clearing and 3D Lightsheet Imaging of the Intact and Injured Spinal Cord in Mice.

McCreedy D, Jalufka F, Platt M, Min S, Kirchhoff M, Pritchard A Front Cell Neurosci. 2021; 15:684792.

PMID: 34408627 PMC: 8366232. DOI: 10.3389/fncel.2021.684792.


Experimental Treatments for Spinal Cord Injury: What you Should Know.

Failli V, Kleitman N, Lammertse D, Hsieh J, Steeves J, Fawcett J Top Spinal Cord Inj Rehabil. 2021; 27(2):50-74.

PMID: 34108834 PMC: 8152172. DOI: 10.46292/sci2702-50.


Targeted Delivery of Erythropoietin Hybridized with Magnetic Nanocarriers for the Treatment of Central Nervous System Injury: A Literature Review.

Hwang C Int J Nanomedicine. 2020; 15:9683-9701.

PMID: 33311979 PMC: 7726550. DOI: 10.2147/IJN.S287456.


References
1.
Xia Y, Zhao T, Li J, Li L, Hu R, Hu S . Antisense vimentin cDNA combined with chondroitinase ABC reduces glial scar and cystic cavity formation following spinal cord injury in rats. Biochem Biophys Res Commun. 2008; 377(2):562-566. DOI: 10.1016/j.bbrc.2008.10.024. View

2.
von Meyenburg J, Brosamle C, Metz G, Schwab M . Regeneration and sprouting of chronically injured corticospinal tract fibers in adult rats promoted by NT-3 and the mAb IN-1, which neutralizes myelin-associated neurite growth inhibitors. Exp Neurol. 1999; 154(2):583-94. DOI: 10.1006/exnr.1998.6912. View

3.
Li S, Liu B, Budel S, Li M, Ji B, Walus L . Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J Neurosci. 2004; 24(46):10511-20. PMC: 6730300. DOI: 10.1523/JNEUROSCI.2828-04.2004. View

4.
Vavrek R, Pearse D, Fouad K . Neuronal populations capable of regeneration following a combined treatment in rats with spinal cord transection. J Neurotrauma. 2007; 24(10):1667-73. DOI: 10.1089/neu.2007.0290. View

5.
ZGraggen W, Metz G, Kartje G, Thallmair M, Schwab M . Functional recovery and enhanced corticofugal plasticity after unilateral pyramidal tract lesion and blockade of myelin-associated neurite growth inhibitors in adult rats. J Neurosci. 1998; 18(12):4744-57. PMC: 6792708. View